semaglutide georgetown Wellness Services Medical Weight Loss GLP-1 in

Sign up for updates on this class action today Visit the GLP-1 Drugs (Ozempic, Mounjaro and Alternatives) class action page and click the join button to subscribe to our database and receive all updates and notices regarding this class action.

Pipeline Innovation: Beyond Weight Loss The obesity pipeline remains robust, and IQVIA estimated there are over 193 assets in development as of October 2025, an increase from 181 assets in development in May 2025

Many patients receive compounded GLP-1 medications in vials and feel unsure about injecting at home

Emerging research also continues to explore how GLP-1 pathways interact with reward signaling in the brain